
Join to view full profile
7373 Perkins RdBaton Rouge, LA 70808
Phone+1 225-246-4572
Dr. Schwartzberg is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Vascular Surgery - Independent, 1985 - 1986
UMass Chan - BaystateResidency, Surgery, 1980 - 1985
Tulane University School of MedicineClass of 1980
Certifications & Licensure
FL State Medical License 2024 - 2027
OH State Medical License 2021 - 2027
MO State Medical License 2022 - 2025
TN State Medical License 2020 - 2024
GA State Medical License 2021 - 2023
LA State Medical License 1980 - 2023
SC State Medical License 2021 - 2023
American Board of Surgery Surgery
American Board of Surgery Vascular Surgery- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- Autologous Arteriovenous Loop Graft Creation for Head and Neck Microsurgical Reconstruction: A Pictorial Essay.Shelby Kitchin, Jake Whiteside, Sabrina Mahanpour, Justin Robbins, Mohamedkazim Alwani
Head & Neck. 2025-09-01 - 28 citationsSelenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study.M. S. Stratton, Mary E. Reid, G. Schwartzberg, F. E. Minter, B. K. Monroe
Anti-Cancer Drugs. 2003-09-01 - 31 citationsSelenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study.M. S. Stratton, Mary E. Reid, G. Schwartzberg, F. E. Minter, B. K. Monroe
Anti-Cancer Drugs. 2003-09-01
Press Mentions
Avinger Announces FDA Clearance of Pantheris for the Treatment of in-Stent RestenosisNovember 19th, 2021
Avinger’s Pantheris System Receives Clearance for Indication to Treat in-Stent Restenosis in Lower Extremity PADNovember 17th, 2021
Avinger Announces Presentations by Key Opinion Leaders at CVC 2019July 16th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:














